Bosnian
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)
encephalitis/fever
Veza se sprema u međuspremnik
Page 1 od 30 rezultati
Compositions and methods for detecting certain flaviviruses, including members of the Japanese encephalitis virus serogroup
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
REFERENCE TO SUBMISSION OF A SEQUENCE LISTING AS A TEXT FILE
The Sequence Listing written in file 88883-873449-000232US.TXT, created on Apr. 16, 2013, 315,044 bytes, machine format IBM-PC, MS-Windows operating system, is hereby incorporated by reference.
BACKGROUND OF THE INVENTION
The family
Compositions and methods for detecting certain Flaviviruses, including members of the Japanese encephalitis virus serogroup
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
BACKGROUND OF THE INVENTION
The family Flaviviridae and genus Flavivirus encompasses a number of viruses that are potentially lethal human pathogens. Such viruses include Dengue virus, Yellow Fever virus, Modoc virus, and viruses of the Japanese encephalitis virus serogroup. The Japanese
Host targeted inhibitors of dengue virus and other viruses
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
BACKGROUND OF THE INVENTION
Dengue virus (DENV) is one of the most significant mosquito-borne viral infections affecting humans today and is an NIAID (National Institute of Allergy and Infectious Diseases) Category A Biodefense pathogen. DENV is a plus-stranded RNA virus and a member of the
Antiviral drugs for treatment or prevention of dengue infection
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
FIELD OF THE INVENTION
This invention relates to the use of benzenesulfonamide derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the flavivirus family such as Dengue fever, Yellow fever, West Nile, St. Louis
Antiviral drugs for treatment or prevention of dengue infection
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
FIELD OF THE INVENTION
This invention relates to the use of benzenesulfonamide derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the flavivirus family such as Dengue fever, Yellow fever, West Nile, St. Louis
Avermectins and milbemycins for the treatment, prevention or amelioration of flavivirus infections
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
CROSS-REFERENCE TO RELATED APPLICATIONS
This application is a National Phase Application of PCT International Application No. PCT/EP2010/065880, International Filing Date, 21 Oct. 2010, claiming priority to European Patent Application No. 09174368.2, filed 28 Oct. 2009, both of which are hereby
Virus purification and formulation process
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
FIELD OF THE INVENTION
The present invention relates generally to a method of purifying biologics, such as a virus or modified virus, and a method of formulating the biologic, for example, a virus and adjuvant.
BACKGROUND OF THE INVENTION
In order to purify a virus it is necessary to remove host
Tick chitinase
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
TECHNICAL FIELD
This invention relates to a tick chitinase.
BACKGROUND ART
Ticks are the cause, directly or indirectly, of extensive damage to animals or humans. Examples of the direct damage are pruritus or bleeding caused by biting or blood-sucking, or tick paralysis or allergic diseases caused by
Methods of inducing an immune response in a host by administering flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
SEQUENCE LISTING
The Sequence Listing is submitted as an ASCII text file, created on Dec. 16, 2011, 5.4 KB, which is incorporated by reference herein.
FIELD OF THE INVENTION
This invention relates to novel vaccines for flaviviruses. In particular, the vaccines are recombinant nucleic acids which
Flavivirus immunogens comprising extracellular viral particles composed of the premembrane (prM) and envelope (E) antigens
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
FIELD OF THE INVENTION
This invention relates to novel vaccines for flaviviruses. In particular, the vaccines are recombinant nucleic acids which contain genes for structural proteins of flaviviruses, such as Japanese encephalitis virus (JEV). These vaccines serve as a transcriptional unit for the
Nucleic acid vaccines for prevention of flavivirus infection
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
FIELD OF THE INVENTION
This invention relates to novel vaccines for flaviviruses. In particular, the vaccines are recombinant nucleic acids which contain genes for structural proteins of flaviviruses, such as Japanese encephalitis virus (JEV). These vaccines serve as a transcriptional unit for the
Methods of preparing carboxy-terminally truncated recombinant flavivirus envelope glycoproteins employing drosophila melanogaster expression systems
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
TECHNICAL FIELD
The invention relates to protection against and diagnosis of dengue fever. More specifically, the invention concerns a subunit of the dengue virus envelope protein secreted as a mature recombinantly produced protein from eucaryotic cells which is protective against dengue infection,
Subunit immonogenic composition against dengue infection
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
TECHNICAL FIELD
The invention relates to protection against and diagnosis of dengue fever. More specifically, the invention concerns a subunit of the dengue virus envelope protein secreted as a mature recombinantly produced protein from eucaryotic cells which is protective against dengue infection,
Treatment and prevention of dengue virus infections
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
FIELD OF THE INVENTION
This invention relates to the use of 2-aryl-benzothiazole or 2-heteroaryl-benzothiazole derivatives and analogs, as well as compositions containing the same, for the treatment or prophylaxis of viral diseases associated with the flavivirus family such as Dengue fever, Yellow
Inhibition and treatment of Hepatitis B virus and Flavivirus by Helioxanthin and its analogs
Samo registrirani korisnici mogu prevoditi članke
Prijavite se / prijavite se
FIELD OF THE INVENTION
This invention relates to the anti-viral drugs such as Helioxanthin and its analogs compounds. These compounds may be used alone or in combination with other drugs for the treatment of the following: Hepatitis B virus (HBV), Hepatitis C virus (HCV), Yellow Fever, Dengue Virus,
Najkompletnija baza ljekovitog bilja potpomognuta naukom
- Radi na 55 jezika
- Biljni lijekovi potpomognuti naukom
- Prepoznavanje biljaka po slici
- Interaktivna GPS karta - označite bilje na lokaciji (uskoro)
- Pročitajte naučne publikacije povezane sa vašom pretragom
- Pretražite ljekovito bilje po učincima
- Organizirajte svoja interesovanja i budite u toku sa istraživanjem vijesti, kliničkim ispitivanjima i patentima
Upišite simptom ili bolest i pročitajte o biljkama koje bi mogle pomoći, unesite travu i pogledajte bolesti i simptome protiv kojih se koristi.
* Sve informacije temelje se na objavljenim naučnim istraživanjima
